Alpa Laboratories Ltd (ALPA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Alpa Laboratories Ltd on NSE and BSE, with an AI summary of each filing.
Alpa Laboratories Limited has submitted the Exchange a copy of Scrutinizer''s Report of its 38th Annual General Meeting.
Annual General Meeting · 12 Oct 2026, 9:23 pm
Summary of Proceedings of 38th Annual General Meeting of the Company held on Wednesday, 30th September 2026 pursuant to Regulation 30 read with Para A of Part A of Schedule III of SEBI ....
Annual General Meeting · 01 Oct 2026, 3:28 am
Appointment of Ms. Diksha Jaswani, as a company secretary cum compliance officer of the company w.e.f September 17,2026.
Change in Management · 17 Sept 2026, 11:37 pm
Alpa Laboratories Appoints Diksha Jaswani as Company Secretary and Compliance Officer Alpa Laboratories Limited has appointed Ms. Diksha Jaswani (Membership No. A80495) as Company Secretary and Compliance Officer (Key Managerial Personnel), effective 17th Sep'26. The appointment was approved by the Board of Directors following recommendations from the Nomination and Remuneration Committee. Ms. Jaswani is an Associate Member of the Institute of Company Secretaries of India with expertise in corporate law, ROC compliance, and regulatory filings. She holds nil shareholding and has no familial relationships with existing company directors.
Annual Report for the Financial Year Ended March 31,2026
Others (Uncategorized) · 08 Sept 2026, 3:10 am
Appointment of Mrs. Radhika Biyani as an Independent Director.
Change in Management · 07 Sept 2026, 7:43 pm
Alpa Laboratories Appoints Radhika Biyani as Independent Director Alpa Laboratories appointed Mrs. Radhika Biyani as Additional Independent Non-Executive Director, effective 5th Sep'26, following the completion of Mrs. Jyoti Jain's tenure on 21st Jul'26 and subsequent DIN allotment. The appointment remains subject to shareholder approval. Consequently, the company reconstituted key board committees, inducting Mrs. Biyani into the Nomination and Remuneration Committee and the Stakeholders Relationship Committee to ensure ongoing regulatory compliance.
Results for the quarter ended June 2026 along with the approval of Notice of 38th Annual General Meeting
Financial Result · 14 Aug 2026, 1:59 am
CLARIFICATION ON BOARD MEETING DATE WITH RESPECT TO THE EARLIER SUBMISSION
Others (Uncategorized) · 11 Aug 2026, 11:27 pm
Alpa Laboratories Clarifies Board Meeting Date Alpa Laboratories Ltd. has clarified a typographical error regarding its upcoming Board Meeting date. The company confirmed via a filing on 11th Aug'26 that the correct date is Thursday, 13th Aug'26, at 3:00 PM. A previous intimation had incorrectly mentioned 14th Aug'26. This correction pertains to the subject line of the earlier portal submission; the details within the main intimation and XBRL filing were correct.
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve 1. The Standalone and Consolidated ....
Intimation · 14 Aug 2026, 5:30 am
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Others (Uncategorized) · 29 Jul 2026, 11:39 pm
Alpa Laboratories Explores Nigerian Pharmaceutical Market Entry Alpa Laboratories Ltd. announced on 29th Jul'26 that it has accorded approval in principle to explore incorporating an overseas company in Nigeria. The proposed entity, named "Alpa Biopharm Limited," would be formed in association with Nigeria-based Blueseal Pharmaceuticals Limited. This new venture is intended to undertake pharmaceutical and healthcare-related business activities. As this is an in-principle approval, details on shareholding, capital contribution, and investment are yet to be finalized, pending necessary statutory and regulatory approvals.
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 , we hereby inform you that Ms. Jyoti Jain has ceased to be an ....
Change in Management · 22 Jul 2026, 9:15 pm
Alpa Laboratories Announces Independent Director Cessation Alpa Laboratories Ltd. announced that Ms. Jyoti Jain (DIN: 07554658) has ceased to be an Independent Director. The cessation is due to the completion of her tenure and is effective from the close of business hours on 21st Jul'26. This change in board composition was disclosed under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements. No further details regarding her profile or inter-director relationships were disclosed, as they were not applicable.
Ms.Yashoda Patidar has resigned from the post of Company Secretary & Complaince Officer w.e.f. 26th July 2026.
Change in Management · 08 Jul 2026, 10:05 pm
Alpa Laboratories Company Secretary & Compliance Officer Resigns Alpa Laboratories announced the resignation of Ms. Yashoda Patidar from her role as Company Secretary and Compliance Officer, citing personal reasons. The resignation was tendered on 08th Jul'26 and will be effective from the close of business hours on 26th Jul'26. This change in key managerial personnel is a notable governance event for the company.
Results for the quarter and year ended March,2026
Financial Result · 30 May 2026, 4:01 am
Alpa Laboratories Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lakh) ■ Revenue: 3,140 (-21.4% YoY | +8.1% QoQ) ■ EBITDA: 360 (+1736.5% YoY | +138.3% QoQ) ■ EBITDA Margin (%): 11.5 (+1097 bps YoY | +626 bps QoQ) ■ PAT: 138 (Loss to Profit YoY | -13.1% QoQ) ■ EPS (INR): 0.24 (Loss to Profit YoY | -68.4% QoQ)
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Standalone & Consolidated ....
Intimation · 29 May 2026, 5:30 am
Alpa Laboratories to Announce Q4 & FY26 Results on 29th May'26 Alpa Laboratories Ltd. has scheduled a Board of Directors meeting for Friday, 29th May'26. The primary agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended 31st Mar'26. The board will also review the corresponding auditor's report. This meeting is crucial for assessing the company's full-year performance and Q4 earnings, which will be key drivers for the stock's near-term direction. The trading window closure was previously announced on 20th Mar'26.
Appointment of Ms.Yashoda Patidar as the Company Secretary and Complaince Officer of the company w.e.f. April 11,2026.
Change in Management · 11 Apr 2026, 9:25 pm
Alpa Laboratories Appoints New Company Secretary and Compliance Officer Alpa Laboratories' Board of Directors has approved the appointment of Ms. Yashoda Patidar as the new Company Secretary and Compliance Officer, effective 11th Apr'26. This key management personnel change was based on the recommendation of the Nomination and Remuneration Committee. Ms. Patidar is an Associate Member of the Institute of Company Secretaries of India (Membership No. A76970). The company confirmed she has no relationship with existing directors and holds no shares in the company.
Clarification on the Price Sensitive Information via email dt8th April,2026
Others (Uncategorized) · 10 Apr 2026, 12:21 am
Alpa Labs Clarifies Stock Movement; Denies Undisclosed Price-Sensitive Information In a letter dated 09th Apr'26, Alpa Laboratories Ltd. responded to an exchange query regarding recent stock price movement. The company clarified that there is no undisclosed price-sensitive information or event that would impact its performance. Alpa Labs further stated it has no upcoming announcements that could affect the stock's price or trading volume. This formal clarification aims to address speculation following the stock's recent activity.
The Exchange has sought clarification from Alpa Laboratories Ltd on April 8, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Others (Uncategorized) · 09 Apr 2026, 12:36 am
The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinit Shah
Others (Uncategorized) · 09 Mar 2026, 3:53 pm
Alpa Labs: Promoter Group Completes Inter-Se Share Transfer On 07 Mar'26, Alpa Laboratories' promoter group executed an inter-se share transfer via gift. Promoter Mr. Vinit Shah acquired 21,940 shares (0.10% stake) from promoter entity Bakulesh Chandulal Shah HUF through an off-market transaction. Post-acquisition, Mr. Shah's holding increased from nil to 0.10%, while the HUF's holding reduced to nil. The total shareholding of the Promoter and Promoter Group remains unchanged. The company's total voting capital stands at 21,040,600 shares before and after the transfer.
The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vinit Shah
Others (Uncategorized) · 09 Mar 2026, 3:47 pm
Alpa Labs: Promoter Group Completes Inter-Se Share Transfer Alpa Laboratories disclosed an inter-se transfer of shares within its Promoter Group on 07 Mar'26. Mr. Vinit Shah acquired 21,940 equity shares, representing 0.10% of the company's capital, from Bakulesh Chandulal Shah HUF. The transaction was conducted off-market as a gift, with no cash consideration. Post-transaction, Mr. Shah's holding increased to 0.10%, while the seller's holding became nil. The overall Promoter and Promoter Group shareholding remains unchanged following this transfer.
Ms Srashti Chopra has resigned from the post of Company Secreatary and Compliance Officer wef 25th March 2026.
Change in Management · 26 Feb 2026, 12:20 am
Alpa Laboratories Company Secretary and Compliance Officer Resigns Alpa Laboratories Ltd. announced that Ms. Srashti Chopra has resigned from her position as Company Secretary and Compliance Officer, citing personal reasons. The resignation, tendered on 25th Feb'26, will be effective from the close of business hours on 25th Mar'26. This key managerial personnel change was reported in compliance with SEBI's LODR Regulations. The company will now begin the process of finding a replacement for this critical compliance role.
Financial Results
Financial Result · 11 Feb 2026, 6:11 pm
Alpa Laboratories Q3 FY26 Standalone Profit Declines YoY on Higher Expenses Alpa Laboratories reported a significant decline in standalone net profit for Q3 FY26, which fell 78.9% YoY to ₹187.48 lacs from ₹889.30 lacs. This was primarily due to a 42.6% YoY surge in the cost of materials consumed. Standalone revenue from operations grew a modest 13.5% YoY to ₹2,967.12 lacs. Sequentially, profit jumped from ₹10.13 lacs in Q2 FY26. Consolidated net profit for the quarter also decreased by 78.6% YoY to ₹190.29 lacs. Basic EPS for the quarter stood at ₹0.89 versus ₹4.24 YoY.
Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
Outcome · 11 Feb 2026, 5:59 pm
Alpa Laboratories Ltd. - Financial Result for the Quarter ended 31st Dec'25 (Consolidated, INR Lacs) ■ Revenue: 2905 (+11.1% YoY | +10.6% QoQ) ■ EBITDA: 151 (+103.2% YoY | Loss to Profit QoQ) ■ EBITDA Margin (%): 5.2 (+236 bps YoY | Loss to Profit QoQ) ■ PAT: 190 (-78.6% YoY | +1591.5% QoQ) ■ EPS (INR): 0.90 (-78.7% YoY | +1700.0% QoQ)
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve the Unaudited Financial results ....
Intimation · 11 Feb 2026, 5:30 am
Alpa Laboratories Board Meeting Set to Approve Q3FY26 Results Alpa Laboratories Ltd. has scheduled a Board of Directors meeting on 11th Feb'26 to consider and approve its standalone and consolidated unaudited financial results for the quarter ended 31st Dec'25. The company's trading window was closed effective 25th Dec'25 in anticipation of this announcement. The meeting will be held at 11:00 A.M. at the company's registered office.
Financial Results for the quarter and half year ended September 30,2025
Financial Result · 15 Nov 2025, 5:24 am
Alpa Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve ALPA LABORATORIES LIMITED ....
Intimation · 14 Nov 2025, 5:30 am
,Alpa Laboratories Limited has submitted the exchange a copy of Scrutinizer''s Report of AGM held on September 29, 2025.
Annual General Meeting · 01 Oct 2025, 10:08 pm